首页> 外文OA文献 >FRI0103 One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study

【2h】

FRI0103 One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study

机译：Fri0103一年的全国性炎性关节炎患者的一年后续随从发起者转向生物仿制物的entaneAncept，专注于转回发起者的患者。一个观察丹比奥研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
B. Glintborg; I.J. Sørensen; E. Omerovic; F. Mehnert; N. Manilo; K. Danebod; D.V. Jensen; H. Nordin; A.G. Loft; O. Hendricks; S. Chrysidis; B.L. Andersen; J.L. Raun; H. Lindegaard; J. Espesen; S.H. Jakobsen; I.M.J. Hansen; E.B. Dalsgaard; D.D. Pedersen; S. Kristensen; A. Linauskas; L.S. Andersen; J. Grydehøj; N.S. Krogh; M.L. Hetland;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational DANBIO study [J] . Glintborg B., Sorensen I. J., Omerovic E., Scandinavian journal of rheumatology . 2018,第Suppla129期

机译：一年的全国性炎性关节炎患者的一年后续随访，他们从发起者转向生物仿制物的entanectpect，专注于转回发起者的患者：观察丹比奥研究
2. To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry [J] . Glintborg Bente, Loft Anne Gitte, Omerovic Emina, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第2期

机译：切换或不切换：从发起者到生物仿制物的强制性切换的全国性指南的结果。 2061例丹比奥登记处炎症关节炎患者的一年治疗结果
3. One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2061 patients with inflammatory arthritis followed in the DANBIO registry [J] . Glintborg B., Sorensen I. J., Omerovic E., Scandinavian journal of rheumatology . 2018,第Suppla129期

机译：一年治疗保留在全国性非医疗开关后从发起者到生物仿生素肠道患者，炎症关节炎患者患者丹比奥登记处
4. Herbal Medicine Containing Aristolochic Acid and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection: A Nationwide Population-Based Cohort Study in Taiwan [C] . Wen-Chao Ho, Chi-Jen Chen, Yao-Hsu Yang, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：含有马兜铃酸的草药和丙型肝炎病毒感染患者肝细胞癌的风险：台湾全国性人群研究
5. A Cost-utility Analysis of Biosimilar Infliximab Compared to Reference Infliximab in Adult Switch Patients with Crohn's Disease: A Canadian Analysis [D] . Hughes, Avery. 2018

机译：生物纤维生素infiximab的成本实用性分析与成人交换患者参考incriximab患者克罗恩病患者：加拿大分析
6. Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar [O] . Anna Felis-Giemza, Kornelia Chmurzyńska, Jolanta Nałęcz-Janik, 2019

机译：依那西普始发者转用依那西普生物仿制药治疗炎性关节炎的观察研究
7. Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar [O] . Anna Felis-Giemza, Kornelia Chmurzyńska, Jolanta Nałęcz-Janik, 2019

机译：Etanercept oundator切换到Etanercept BioSimilar的炎症性关节炎治疗的观察性研究

FRI0103 One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study

著录项

相似文献

相关主题

期刊订阅